Scarlet Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.3M

  • Investors
  • 8

Scarlet Therapeutics General Information

Description

Developer of a healthcare platform that generates red blood-based therapeutics intended to treat a wide range of diseases. The company's cells carry additional proteins within them to provide a therapeutic benefit and pervasive reach throughout the body and can be used in the treatment of diseases such as hyperammonemia, hyperoxaluria, other metabolic diseases, cancer, and autoimmune diseases, enabling the healthcare industry to treat diseases with more efficacious therapies.

Contact Information

Website
www.scarlet-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Creates, Old Market
  • Midland Road, Somerset
  • Bristol BS2 0JZ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Science Creates, Old Market
  • Midland Road, Somerset
  • Bristol BS2 0JZ
  • England, United Kingdom

Scarlet Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scarlet Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 07-May-2026 $4.3M Completed Product Development
4. Grant 07-Dec-2023 Completed Product Development
3. Seed Round 23-Apr-2023 Completed Product Development
2. Seed Round 12-Aug-2022 $2.41M $2.41M Completed Product Development
1. Spin-Off 28-Jul-2021 Completed Startup
To view Scarlet Therapeutics’s complete valuation and funding history, request access »

Scarlet Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B Ordinary
A Ordinary
A Ordinary 1,336,205 $0.000135 $3.13 $3.13 1x $3.13 36.51%
To view Scarlet Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Scarlet Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scarlet Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daft Capital Venture Capital Minority
Eos Advisory Venture Capital Minority
Oshen Holdings Family Office Minority
Innovate UK Government
Science Creates Accelerator/Incubator Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Scarlet Therapeutics FAQs

  • When was Scarlet Therapeutics founded?

    Scarlet Therapeutics was founded in 2021.

  • Where is Scarlet Therapeutics headquartered?

    Scarlet Therapeutics is headquartered in Bristol, United Kingdom.

  • What is the size of Scarlet Therapeutics?

    Scarlet Therapeutics has 8 total employees.

  • What industry is Scarlet Therapeutics in?

    Scarlet Therapeutics’s primary industry is Drug Discovery.

  • Is Scarlet Therapeutics a private or public company?

    Scarlet Therapeutics is a Private company.

  • What is the current valuation of Scarlet Therapeutics?

    The current valuation of Scarlet Therapeutics is .

  • What is Scarlet Therapeutics’s current revenue?

    The current revenue for Scarlet Therapeutics is .

  • How much funding has Scarlet Therapeutics raised over time?

    Scarlet Therapeutics has raised $8.08M.

  • Who are Scarlet Therapeutics’s investors?

    Daft Capital, Eos Advisory, Oshen Holdings, Innovate UK, and Science Creates are 5 of 8 investors who have invested in Scarlet Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process